DW30
UTHR icon

Drucker Wealth 3.0’s United Therapeutics UTHR Stock Holding History

Drucker Wealth 3.0’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Buy
641
+23
+4% +$13K 0.05% 211
2026
Q1 		$366K Sell
618
-48
-7% -$23.9K 0.06% 190
2025
Q4 		$325K Buy
666
+114
+21% +$53.1K 0.06% 200
2025
Q3 		$231K Buy
+552
New +$186K 0.04% 234

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Drucker Wealth 3.0's UTHR Position: Q2 2026 in Review

Drucker Wealth 3.0 increased its United Therapeutics (UTHR) stake by 3.7% in Q2 2026, buying an estimated $13K and bringing the position to 641 shares worth $347K. The position accounts for 0.05% of the portfolio, ranked #211.

Drucker Wealth 3.0 first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $366K in Q1 2026. 107 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Drucker Wealth 3.0 held 641 shares of United Therapeutics worth $347K as of Q2 2026.
  • Drucker Wealth 3.0 bought 23 United Therapeutics shares in Q2 2026, an estimated $13K.
  • United Therapeutics made up 0.05% of Drucker Wealth 3.0's portfolio in Q2 2026, its #211 holding.
  • Drucker Wealth 3.0 first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Drucker Wealth 3.0's United Therapeutics position peaked at $366K in Q1 2026.
  • 107 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Drucker Wealth 3.0's 13F filing for Q2 2026, filed 13 Jul 2026.